IBD |
Inflammatory bowel disease |
BMI |
Body mass index |
TNBC |
Triple-negative breast cancer |
IBC |
Inflammatory breast cancer |
E coli |
Escherichia coli |
SCFA |
Short chain fatty acids |
IL |
Interleukin |
TNF |
Tumor necrosis factor |
CRP |
C reactive protein |
ERβ |
Estrogen receptor beta |
PD |
Periodontal disease |
NSAID |
Non-steroidal anti-inflammatory drugs |
HR |
Hazard ratio |
ERα |
Estrogen receptor alpha |
AR |
Androgen receptor |
PR |
Progesterone receptor |
Her2 |
Human epidermal growth factor receptor 2 |
GPCR |
G-protein coupled receptor |
HAT |
Histone acetyltransferases |
AhR |
Aryl hydrocarbon receptor |
GI |
Gastrointestinal |
SBA |
Secondary bile acids |
LCA |
Lithocholic acid |
TCA |
Tricarboxylic acid |
EMT |
Epithelial to mesenchymal transition |
VEGF |
Vascular endothelial growth factor |
COX-2 |
Cyclooxygenase 2 |
PGE2 |
Prostaglandin E2 |
TLR |
Toll-like receptors |
TIMER |
Translocation, Immunomodulation, Metabolism, Enzymatic degradation and Reduced diversity |